Form 4: Novavax Executive James Patrick Kelly Reports Stock Option and Restricted Stock Unit Grant

EVP, CFO, and Treasurer of Novavax, James Patrick Kelly, reports the acquisition of stock options and restricted stock units.

Summary

• On March 3, 2025, James Patrick Kelly, EVP, CFO, and Treasurer of Novavax, reported the acquisition of 194,500 non-statutory stock options and 129,500 restricted stock units (RSUs).
• The stock options have an exercise price of $7.87 and expire on March 3, 2035.
• 25% of the stock options vest on the first anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over the following three years, contingent upon continued employment.
• One-third of the RSUs vest on each of the first three anniversaries of the grant date, also subject to continued employment.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Risks

• The vesting of the options and RSUs is contingent upon continued employment, which could be a risk if the executive were to leave the company.

Industry Context

Stock options and RSUs are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are common in the biotech industry.
• Companies like Moderna (MRNA) and BioNTech (BNTX) also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules described are fairly standard, aligning with typical industry practices for retaining key personnel.

Stakeholder Impact

• Shareholders may view the grant of stock options and RSUs positively as it incentivizes management to increase shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates